164 related articles for article (PubMed ID: 35585301)
1. From 1901 to 2022, how far are we from truly understanding the pathogenesis of age-related dementia?
Fang X; Zhang J; Roman RJ; Fan F
Geroscience; 2022 Jun; 44(3):1879-1883. PubMed ID: 35585301
[TBL] [Abstract][Full Text] [Related]
2. Reversal of cerebral hypoperfusion: a novel therapeutic target for the treatment of AD/ADRD?
Fan F; Roman RJ
Geroscience; 2021 Apr; 43(2):1065-1067. PubMed ID: 33772733
[TBL] [Abstract][Full Text] [Related]
3. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
de la Torre J
J Alzheimers Dis; 2018; 63(1):35-52. PubMed ID: 29614675
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
5. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
6. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
7. A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.
Mukhopadhyay S; Banerjee D
J Alzheimers Dis; 2021; 83(4):1537-1552. PubMed ID: 34366359
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Disease-Related Dementias Summit 2019: National Research Priorities for the Investigation of Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease and Related Dementias.
Dams-O'Connor K; Bellgowan PSF; Corriveau R; Pugh MJ; Smith DH; Schneider JA; Whitaker K; Zetterberg H
J Neurotrauma; 2021 Dec; 38(23):3186-3194. PubMed ID: 34714152
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disease-Related Dementias Summit 2022: National Research Priorities for the Investigation of Post-Traumatic Brain Injury Alzheimer's Disease and Related Dementias.
Dams-O'Connor K; Awwad HO; Hoffman S; Pugh MJ; Johnson VE; Keene CD; McGavern L; Mukherjee P; Opanashuk L; Umoh N; Sopko G; Zetterberg H
J Neurotrauma; 2023 Aug; 40(15-16):1512-1523. PubMed ID: 36927167
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
11. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling.
Fang X; Border JJ; Rivers PL; Zhang H; Williams JM; Fan F; Roman RJ
Geroscience; 2023 Oct; 45(5):2909-2926. PubMed ID: 37326915
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular Dysfunction in Alzheimer's Disease and Transgenic Rodent Models.
Fang X; Fan F; Border JJ; Roman RJ
J Exp Neurol; 2024; 5(2):42-64. PubMed ID: 38434588
[TBL] [Abstract][Full Text] [Related]
15. High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner.
Gannon OJ; Robison LS; Salinero AE; Abi-Ghanem C; Mansour FM; Kelly RD; Tyagi A; Brawley RR; Ogg JD; Zuloaga KL
J Neuroinflammation; 2022 May; 19(1):110. PubMed ID: 35568928
[TBL] [Abstract][Full Text] [Related]
16. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
17. Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia.
Wang P; Velagapudi R; Kong C; Rodriguiz RM; Wetsel WC; Yang T; Berger M; Gelbard HA; Colton CA; Terrando N
Alzheimers Dement; 2020 May; 16(5):734-749. PubMed ID: 32291962
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
Henry-Feugeas MC
Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
[TBL] [Abstract][Full Text] [Related]
19. Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.
Haddad HW; Malone GW; Comardelle NJ; Degueure AE; Kaye AM; Kaye AD
Health Psychol Res; 2022; 10(1):31925. PubMed ID: 35928986
[TBL] [Abstract][Full Text] [Related]
20. Neurovascular coupling preserved in a chronic mouse model of Alzheimer's disease: Methodology is critical.
Sharp PS; Ameen-Ali KE; Boorman L; Harris S; Wharton S; Howarth C; Shabir O; Redgrave P; Berwick J
J Cereb Blood Flow Metab; 2020 Nov; 40(11):2289-2303. PubMed ID: 31760864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
